Wholesale of pharmaceutical and medical goods
NORGINE NORGE AS
Revenue 2024
NOK 15.8m
Operating profit
NOK 753,000
Equity
NOK 9.9m
Incorporated
2006
Share capital
NOK 100,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 15.8m | |
| Total operating costs | 15.1m | |
| Operating profit (EBIT) | 753k | |
| Net financial items | 472k | |
| Profit for the year | 719k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 18.7m | |
| of which current assets | 18.7m | |
| Equity | 9.9m | |
| Total liabilities | 8.8m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.